Each one effervescent contains:
Paracetamol | 325 mg |
Treatment of mild to moderate pain and fever.
POSOLOGY AND METHOD OF ADMINISTRATION
Method of administration
Effer-Paralmax 325 is for oral administration, dissolve the tablets in water, drink after these tablets are completely effervescent.
Posology
Adults and children above 12 years of age: 2 tablets every 4 - 6 hours. Maximum dose of 12 tablets in 24 hours.
Children 6 – 11 years: 1 tablet every 4 - 6 hours. Maximum dose of 5 tablets in 24 hours.
Not recommended for children under 6 years of age.
CONTRAINDICATIONS
Hypersensitivity to any of the ingredients of the drug.
Patients with severe hepatic impairment.
WARNINGS AND PRECAUTION
Special warnings and precautions for use
Caution is advised in the administration of paracetamol to patients with renal insufficiency, hepatic insufficiency, chronic malnutrition, and dehydration.
Patients should be advised not to take other paracetamol-containing products concurrently.
Paracetamol is not recommended for use in children under 6 years of age.
Paracetamol may cause severe skin reactions. Symptoms may include skin reddening, blisters, or a rash. If a skin reaction occurs, stop use and seek medical assistance right away.
Prolonged or frequent use is discouraged. Taking a high dose of p-aminophenol derivatives drugs regularly for a long time can cause thrombocytopenia, leukopenia, and pancytopenia.
Neutropenia and hemorrhage also may occur.
The very rare occurrence of agranulocytosis in patients taking paracetamol.
Caution is advised in the administration of paracetamol to patients with glucose-6-phosphate dehydrogenase deficiency.
Caution is advised in the administration of paracetamol to anemic patients.
Caution should be exercised in cases of chronic alcoholism. Alcohol should not be used during the treatment with paracetamol due to hepatotoxicity.
Effer-Paralmax 325 contains aspartame, which is a source of phenylalanine. This may be harmful to patients with phenylketonuria
This medicine contains 380.62 mg sodium in each effervescent tablet. Caution should be exercised in patients who have been advised to follow a low salt (sodium) diet.
Physicians should warn patients about the signs of severe skin reactions such as Steven-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), Lyell's syndrome, and acute generalize exanthematous pustulosis (AGEP).
Recommendations for pregnant and lactating women
Pregnancy
A large amount of data on pregnant women indicates neither malformation nor feto/neonatal toxicity.
Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically needed, paracetamol can be used during pregnancy however it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency.
Paracetamol should not be used with high-dose for a long time or concomitant treatment with other medicinal products during pregnancy.
Lactation
Paracetamol is excreted in breast milk in small quantities. Paracetamol can be administered during breast-feeding, however, the recommended dose should not be exceeded
Effects of drugs on the ability to drive and use machines
Paracetamol has no influence on the ability to drive and use machines.
SHELF-LIFE
36 months from the manufacturing date. Do not use after the expiry date.
Aluminum/Aluminum strip. Box of 05 strips x 04 effervescent tablets
Aluminum/Aluminum strip. Box of 10 strips x 04 effervescent tablets